Luiz Otávio Guimarães-Ervilha

Dr. Luiz Otávio Guimarães-Ervilha


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2018 in Life Sciences
Verified
Journal Article
Closed access
ASAna Cláudia Ferreira Souza
Ana Cláudia Ferreira Souza
DBDaniel Silva Sena Bastos
Daniel Silva Sena Bastos
FSFelipe Couto Santos
Felipe Couto Santos
MSMarcela Nascimento Sertorio
Marcela Nascimento Sertorio
LGLuiz Otávio Guimarães-Ervilha
Luiz Otávio Guimarães-Ervilha
MMMariana Machado-Neves
Mariana Machado-Neves

17 June 2019 in Andrology
Verified
Journal Article
Closed access
PDF file
ASAna Cláudia Ferreira Souza
Ana Cláudia Ferreira Souza
DBDaniel Silva Sena Bastos
Daniel Silva Sena Bastos
MSM. N. Sertorio
M. N. Sertorio
FSF. C. Santos
F. C. Santos
LGLuiz Otávio Guimarães-Ervilha
Luiz Otávio Guimarães-Ervilha
MMMariana Machado-Neves
Mariana Machado-Neves

7 March 2019 in Environmental Science and Pollution Research
Verified
Journal Article
Closed access
PDF file
MSMarcela Nascimento Sertorio
Marcela Nascimento Sertorio
ASAna Cláudia Ferreira Souza
Ana Cláudia Ferreira Souza
DBDaniel Silva Sena Bastos
Daniel Silva Sena Bastos
FSFelipe Couto Santos
Felipe Couto Santos
LGLuiz Otávio Guimarães-Ervilha
Luiz Otávio Guimarães-Ervilha
MMMariana Machado-Neves
Mariana Machado-Neves

1 September 2020 in Life Sciences
Verified
Journal Article
Closed access
ASAna Cláudia Ferreira Souza
Ana Cláudia Ferreira Souza
JCJohn Lennon de Paiva Coimbra
John Lennon de Paiva Coimbra
LGLuiz Otávio Guimarães-Ervilha
Luiz Otávio Guimarães-Ervilha
DBDaniel Silva Sena Bastos
Daniel Silva Sena Bastos
JCJamile Fernanda Silva Cossolin
Jamile Fernanda Silva Cossolin
MMMariana Machado-Neves
Mariana Machado-Neves

1 June 2020 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
DBDaniel Silva Sena Bastos
Daniel Silva Sena Bastos
BMBianca Meirelles Miranda
Bianca Meirelles Miranda
TMThais Viana Fialho Martins
Thais Viana Fialho Martins
LGLuiz Otávio Guimarães-Ervilha
Luiz Otávio Guimarães-Ervilha
ASAna Cláudia Ferreira Souza
Ana Cláudia Ferreira Souza
EMEduardo de Almeida Marques-Da-Silva
Eduardo de Almeida Marques-Da-Silva
In this work, we aimed to evaluate the effects of the Leishmania infantum chagasi infection on the liver of vaccinated mice, considering parameters of tissue damage and the inflammatory response elicited by vaccination. We used recombinant LPG3 protein (rLPG3) as immunogen in BALB/c mice before challenge with promastigote forms of L. infantum chagasi. The animals were separated into five groups: NI: non-infected animals; NV: non-vaccinated; SAP: treated with saponin; rLPG3: immunized with rLPG3; rLPG3 + SAP: immunized with rLPG3 plus SAP. The experiment was conducted in replicate, and the vaccination protocol consisted of three subcutaneous doses of rLPG3 (40 μg + two boosters of 20 μg). The mice were challenged two weeks after the last immunization. Our results showed that rLPG3 + SAP immunization decreased the parasite burden in 99 %, conferring immunological protection in the liver of the infected animals. Moreover, the immunization improved the antioxidant defenses, increasing CAT and GST activity, while reducing the levels of oxidative stress markers, such as H2O2 and NO3/NO2, and carbonyl protein in the organ. As a consequence, rLPG3 + SAP immunization preserved tissue integrity and reduced the granuloma formation, inflammatory infiltrate and serum levels of AST, ALT, and ALP. Taken together, these results showed that rLPG3 vaccine confers liver protection against L. infantum chagasi in mice, while maintaining the liver tissue protected against the harmful inflammatory effects caused by the vaccine followed by the infection.

24 August 2022 in Arquivos Brasileiros de Cardiologia
Verified
Journal Article
Open access
PDF file
LSLeôncio Lopes Soares
Leôncio Lopes Soares
Luciano Bernardes LeiteLuciano Bernardes Leite
Luciano Bernardes Leite
LGLuiz Otávio Guimarães-Ervilha
Luiz Otávio Guimarães-Ervilha
BSBruna Aparecida Fonseca da Silva
Bruna Aparecida Fonseca da Silva
MFMaíra Oliveira de Freitas
Maíra Oliveira de Freitas
ANANTONIO JOSE NATALI
ANTONIO JOSE NATALI
Resumo Fundamento A hipertrofia e a dilatação do ventrículo direito observadas na hipertensão arterial pulmonar (HAP) prejudicam a dinâmica do ventrículo esquerdo (VE) achatando o septo interventricular. Objetivo Investigar se o treinamento físico resistido (TFR) de intensidade baixa a moderada é benéfico para funções contráteis do VE e de cardiomiócitos em ratos durante o desenvolvimento de HAP induzida por monocrotalina (MCT). Métodos Foram usados ratos Wistar machos (Peso corporal: ~ 200 g). Para avaliar o tempo até o possível surgimento [...] Resumo Fundamento A hipertrofia e a dilatação do ventrículo direito observadas na hipertensão arterial pulmonar (HAP) prejudicam a dinâmica do ventrículo esquerdo (VE) achatando o septo interventricular. Objetivo Investigar se o treinamento físico resistido (TFR) de intensidade baixa a moderada é benéfico para funções contráteis do VE e de cardiomiócitos em ratos durante o desenvolvimento de HAP induzida por monocrotalina (MCT). Métodos Foram usados ratos Wistar machos (Peso corporal: ~ 200 g). Para avaliar o tempo até o possível surgimento